These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2014001)

  • 1. A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.
    Hanna PC; McClane BA
    Mol Microbiol; 1991 Jan; 5(1):225-30. PubMed ID: 2014001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity.
    McClane BA; Wnek AP
    Infect Immun; 1990 Sep; 58(9):3109-15. PubMed ID: 2117579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli.
    Czeczulin JR; Hanna PC; McClane BA
    Infect Immun; 1993 Aug; 61(8):3429-39. PubMed ID: 8335373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.
    Smedley JG; Uzal FA; McClane BA
    Infect Immun; 2007 May; 75(5):2381-90. PubMed ID: 17307943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity induced by Clostridium perfringens isolate carrying a chromosomal cpe gene is exclusively dependent on sporulation and enterotoxin production.
    Yasugi M; Sugahara Y; Hoshi H; Kondo K; Talukdar PK; Sarker MR; Yamamoto S; Kamata Y; Miyake M
    Microb Pathog; 2015 Aug; 85():1-10. PubMed ID: 25912832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion analysis of the Clostridium perfringens enterotoxin.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1997 Mar; 65(3):1014-22. PubMed ID: 9038311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.
    Hanna PC; Mietzner TA; Schoolnik GK; McClane BA
    J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.
    Hanna PC; Wnek AP; McClane BA
    J Bacteriol; 1989 Dec; 171(12):6815-20. PubMed ID: 2556374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.
    Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA
    Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.
    Wnek AP; McClane BA
    Infect Immun; 1989 Feb; 57(2):574-81. PubMed ID: 2536357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes.
    McClane BA
    Toxicology; 1994 Feb; 87(1-3):43-67. PubMed ID: 8160188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.
    Wieckowski EU; Kokai-Kun JF; McClane BA
    Infect Immun; 1998 Dec; 66(12):5897-905. PubMed ID: 9826371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo.
    Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA
    Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin.
    Wieckowski EU; Wnek AP; McClane BA
    J Biol Chem; 1994 Apr; 269(14):10838-48. PubMed ID: 8144671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.
    Yelland TS; Naylor CE; Bagoban T; Savva CG; Moss DS; McClane BA; Blasig IE; Popoff M; Basak AK
    J Mol Biol; 2014 Sep; 426(18):3134-3147. PubMed ID: 25020226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of Clostridium perfringens enterotoxin.
    McClane BA
    Toxicon; 1996; 34(11-12):1335-43. PubMed ID: 9027990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that alterations in small molecule permeability are involved in the Clostridium perfringens type A enterotoxin-induced inhibition of macromolecular synthesis in Vero cells.
    Hulkower KI; Wnek AP; McClane BA
    J Cell Physiol; 1989 Sep; 140(3):498-504. PubMed ID: 2550473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.
    Long H; Crean CD; Lee WH; Cummings OW; Gabig TG
    Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions.
    McClane BA
    Toxicon; 2001 Nov; 39(11):1781-91. PubMed ID: 11595640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Effects of Mepacrine against
    Navarro MA; Shrestha A; Freedman JC; Beingesser J; McClane BA; Uzal FA
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.